These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9120466)

  • 1. A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.
    Albani C; Albani G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):418. PubMed ID: 9120466
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.
    Ozden MG; Erel A; Erdem O; Oztas MO
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):112-3. PubMed ID: 15649205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.
    Weinberg JM; Wolfe JT; Sood S; Saruk M; Rook AH; Spiers EM
    Acta Derm Venereol; 1997 Mar; 77(2):146-8. PubMed ID: 9111829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis.
    Inafuku H; Kasem Khan MA; Nagata T; Nonaka S
    J Dermatol; 2004 Aug; 31(8):671-7. PubMed ID: 15492442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b.
    Casoni F; Merelli E; Bedin R; Martella A; Cesinaro A; Bertolotto A
    Mult Scler; 2003 Aug; 9(4):420-3. PubMed ID: 12926849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous reactions following subcutaneous beta-interferon-1b injection.
    Ohata U; Hara H; Yoshitake M; Terui T
    J Dermatol; 2010 Feb; 37(2):179-81. PubMed ID: 20175855
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis.
    Feldmann R; Löw-Weiser H; Duschet P; Gschnait F
    Dermatology; 1997; 195(1):52-3. PubMed ID: 9267740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More on interferon-induced cutaneous necrosis.
    Shinohara K
    N Engl J Med; 1995 Nov; 333(18):1222; author reply 1223-4. PubMed ID: 7565992
    [No Abstract]   [Full Text] [Related]  

  • 10. [Skin reactions to interferon alpha in a series of 92 patients with multiple sclerosis].
    Fortuño Y; Marcoval J; Gallego I; Moreno A; Arbizu T; Peyrí J
    Med Clin (Barc); 1999 Oct; 113(12):447-8. PubMed ID: 10570511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal neuropathy associated with cutaneous necrosis at the site of interferon-beta injection for multiple sclerosis.
    Créange A; Lefaucheur JP
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):395. PubMed ID: 10787312
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.
    Elgart GW; Sheremata W; Ahn YS
    J Am Acad Dermatol; 1997 Oct; 37(4):553-8. PubMed ID: 9344192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous necrosis associated with recombinant interferon injection.
    Weinberg JM
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):807-8. PubMed ID: 9810903
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis.
    Szilasiová J; Gdovinová Z; Jautová J; Baloghová J; Ficová M; Bohus P
    Clin Neuropharmacol; 2009; 32(5):301-3. PubMed ID: 19820436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.
    Sheremata WA; Taylor JR; Elgart GW
    N Engl J Med; 1995 Jun; 332(23):1584. PubMed ID: 7739724
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b.
    Cohen BA; Greenberger PA; Saini S
    Allergy Asthma Proc; 1998; 19(2):85-8. PubMed ID: 9578917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to therapy: using an evidence-based protocol.
    Moore LA; Kaufman MD; Algozzine R; Irish N; Martin M; Posey CR
    Rehabil Nurs; 2007; 32(6):227-32. PubMed ID: 18065143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.
    Wells J; Kossard S; McGrath M
    Australas J Dermatol; 2005 Aug; 46(3):202-4. PubMed ID: 16008658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.